All Pharma News
SCOTUS declines to review former Insys founder John Kapoor`s conviction

SCOTUS declines to review former Insys founder John Kapoor`s conviction
Zachary Brennan ENDPTS
13 Jun 2022
Share Share
Ex-Insys execs owe nearly $50M in opioid restitution

Ex-Insys execs owe nearly $50M in opioid restitution
Fraiser Kansteiner FIERCEPHARMA
30 Nov 2021
Share Share
National Comprehensive Cancer Network® Adds Monjuvi® (tafasitamab-cxix)

National Comprehensive Cancer Network® Adds Monjuvi® (tafasitamab-cxix)
BUSINESSWIRE
18 Aug 2020
Share Share
Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy

Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy
LAW360
17 Aug 2020
Share Share
Insys Execs Can`t Dodge Prison During Appeal, Seek Delay

Insys Execs Can`t Dodge Prison During Appeal, Seek Delay
WWW.LAW360
02 Jul 2020
Share Share
Opioid executive admits to ‘no morals’ ahead of prison term

Opioid executive admits to ‘no morals’ ahead of prison term
H. Kuchler FINANCIAL TIMES
24 Jan 2020
Share Share
Former Insys exec decries sexist hiring in sentencing memo

Former Insys exec decries sexist hiring in sentencing memo
Kyle Blankenship FIERCE PHARMA
23 Jan 2020
Share Share
Opioid-Maker Insys Wins Court Approval of Bankruptcy Plan

Opioid-Maker Insys Wins Court Approval of Bankruptcy Plan
Peg Brickley WSJ
17 Jan 2020
Share Share
Former Insys VP tagged with 33-month sentence in Subsys kickback scheme

Former Insys VP tagged with 33-month sentence in Subsys kickback scheme
Kyle Blankenship FIERCE PHARMA
15 Jan 2020
Share Share
Federal judge overturns part of Insys founder Kapoor`s racketeering conviction

Federal judge overturns part of Insys founder Kapoor`s racketeering conviction
K. Blankenship FIERCE PHARMA
29 Nov 2019
Share Share